drugset / Trial / NCT04794738

A Clinical Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery

NCT04794738

Phase 2/3 Unknown 192 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to evaluate the analgesic efficacy of IV SHR8554 compared with placebo and morphine in patients with acute postoperative pain following orthopedic surgery.

Timeline

Start
2021-04-18
Primary completion
2021-10-30
Completion
2021-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified
Subject SHR8554 Unknown Intravenous

Indications

No indication recorded.